Routine vaccination with human papillomavirus vaccines have resulted in an 87% reduction in cervical cancer cases in England, and could even see the need for smear tests phased out in future, ...

Dublin, April 30, 2025 (GLOBE NEWSWIRE) -- The "Cervarix Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" report has been added to ResearchAndMarkets.com's offering.

One dose of a human papillomavirus (HPV) vaccine was noninferior to two doses in preventing infection, data from a randomized trial showed. In the ESCUDDO trial, which involved more than 20,000 girls ...

China has granted a green light for Glaxosmithkline plc’s human papillomavirus (HPV) vaccine, Cervarix, for girls ages 9 to 14. The HPV bivalent vaccine is used against types 16 and 18 in a two-dose ...

China approves Cervarix two-dose vaccine schedule for girls aged 9 to 14 against certain types of cancer-causing human papillomavirus · China's National Medical Products Administration (NMPA) has ...

Researchers find substantial reduction among young women who have received the jab Young women who were vaccinated against human papillomavirus (HPV) in their teens with an older GlaxoSmithKline ...

An earlier version of the human papillomavirus (HPV) vaccine dramatically reduced the rates of cervical cancer among women offered the shot when they were 12 and 13, according to research from the U.K ...

Young women who were vaccinated against the human papillomavirus (HPV) in their teens with an older GlaxoSmithKline product called Cervarix had up to an 87% lower risk of developing cervical cancer ...

Cervical cancer cases plummeted among British women and girls who received a vaccination against the human papillomavirus (HPV), according to a new study. The results published in The Lancet medical ...

Editor's Note: We at POPSUGAR recognize that people of many genders and identities, including but not limited to women, may or may not have female sex organs, such as a cervix or vagina. This ...